The Influence of Multiple‐Dose Vorapaxar, an Oral PAR‐1 Receptor Antagonist, on the Single‐Dose Pharmacokinetics and Pharmacodynamics of Digoxin
暂无分享,去创建一个
D. Cutler | T. Kosoglou | P. Statkevich | Yali Zhu | A. Johnson‐Levonas | F. Xuan | James E. Schiller | D. Cutler | Amy O. Johnson‐Levonas